Vaxxinity Accounts Payable

Vaxxinity (VAXX) currently reports a accounts payable of $1.8M as of December 2023. That compares with $5.3M in the prior-year period — down 66.3% year over year. Use the charts on this page to explore Vaxxinity's accounts payable history and peer comparisons.

Vaxxinity's accounts payable decreased from $5.3M to $1.8M — a 66.3% year-over-year decrease (period ending December 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Vaxxinity reported $1.8M in accounts payable as of December 2023. That compares with $5.3M in the prior-year period — down 66.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $1.8M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Vaxxinity, and consider following VAXX for alerts when major investors trade the stock.